عسر الطمث
مراجعة من قبل الدكتورة فيليبا فينسنت، MRCGPآخر تحديث بواسطة الدكتورة توني هازيل، زميلة الكلية الملكية للأطباء العامينآخر تحديث 7 Mar 2025
يتوافق مع الإرشادات التحريرية
- تنزيلتنزيل
- مشاركة
- Language
- نقاش
- Ask Patient
- نسخة صوتية
- أضف إلى المصادر المفضلة على جوجل
المهنيين الطبيين
تم تصميم مقالات المراجع المهنية لاستخدامها من قبل المتخصصين في الرعاية الصحية. يتم كتابتها بواسطة أطباء من المملكة المتحدة وتستند إلى أدلة بحثية وإرشادات المملكة المتحدة وأوروبا. قد تجد الدورات الشهرية ومشاكلها مقالة أكثر فائدة، أو واحدة من مقالاتنا الأخرى مقالاتنا الصحية.
What is dysmenorrhoea?
Dysmenorrhoea is a term used to describe low anterior pelvic pain which occurs in association with periods.
التسبب في المرض1
It is thought to be due to an excess or imbalance of prostaglandins and leukotrienes in the menstrual fluid, which in turn produces vasoconstriction in the uterine vessels, causing the uterine contractions which produce the pain. The prostaglandin release may also be responsible for the symptoms of diarrhoea, nausea, headache and light-headedness which may occur in association with dysmenorrhoea.
تصنيف
Dysmenorrhoea may be thought of as either primary or secondary.
Primary dysmenorrhoea2
Primary dysmenorrhoea is idiopathic. It often begins with the onset of ovulatory cycles six months to one year after the menarche. The pain begins with the onset of the period, or just before, and may last for 24-72 hours.
Secondary dysmenorrhoea
Secondary dysmenorrhoea occurs in association with some form of pelvic pathology:
It is more likely to start years after onset of menstruation.
The pain can precede the start of the period by several days and may last throughout the period. As the pathology progress, there may be pelvic pain which is constant and not cyclical.
There may be associated dyspareunia.
Secondary dysmenorrhoea may occur as a result of:
Fibroids, when it is often associated with heavy menstrual bleeding.
Adhesions.
The copper-containing intrauterine contraception device (Cu-IUCD) may cause increased dysmenorrhoea, though there is little long-term data.
How common is dysmenorrhoea? (Epidemiology)2
Dysmenorrhoea is common. Prevalence rates vary widely and range from 17-91% in women of reproductive age, with severe pain reported in 2-29% of women.
Longer duration of menses, early menarche and smoking are all risk factors associated with dysmenorrhoea.
A weight which is over or under the ideal range may increase the risk of dysmenorrhoea; one review found that this decreased for women with obesity who lost weight, but persisted for women who were underweight and then gained weight. However a 2022 systematic review said that more research was needed to clarify the increased risk, if any, relating to obesity.34
Childbirth may reduce dysmenorrhoea, with the most significant reduction occurring after the first birth and the severity of primary dysmenorrhoea may reduce with age.567
تقييم2
A presumptive diagnosis of primary dysmenorrhoea may be made on history and abdominal examination alone in young patients who are not sexually active, and vaginal examination is not normally required in this group of patients. All women should have an abdominal examination, which will detect a large fibroid uterus and other masses.
Investigation of dysmenorrhoea is primarily aimed at ruling out underlying pathology and may include any or all of the following as appropriate to the individual.
التاريخ
Age at menarche.
Cycle length.
Whether the cycle is regular.
Duration of bleeding.
Timing of pain in relation to period.
Location of pain. Dysmenorrhoea is typically suprapubic but may be felt in the back of the legs or lower back
Smoking history.
Whether the patient is sexually active. Always see a teenager alone to ask this question, rather than in the presence of parents or friends.
Obstetric history.
Contraceptive history.
Any features suggestive of underlying pathology (for example, vaginal discharge, intermenstrual or postcoital bleeding, dyspareunia).
Dyschezia and/or rectal pain or bleeding - this is particularly suggestive of endometriosis, as are cyclical symptoms elsewhere in the body for example, cyclical nosebleeds or shoulder tip pain.
الفحص
A vaginal examination is indicated if the woman is sexually active. However, a normal examination doesn't exclude pathology such as endometriosis and should not be used as reassurance if there are clinical features that suggest secondary dysmenorrhoea.
Adenomyosis - the uterus may be enlarged and tender with a typical 'boggy' feel.
Endometriosis - generalised tenderness in the pelvic area. The uterus may be fixed ± retroverted due to adhesions, and nodules may be palpable in the uterosacral ligaments.
Partially imperforate hymen (rare).
Vaginal septum (rare).
Additional investigations
Speculum examination to visualise the cervix.
High vaginal swab, chlamydial swabs.
Cervical smear, if due.
Pelvic ultrasound - if uterine enlargement or adnexal mass is present or there is suspicion of a secondary cause. As with examination, a normal ultrasound doesn't exclude endometriosis. A transvaginal scan will be more sensitive at picking up pathology than an abdominal one.
Specialist investigations
MRI scan.
Laparoscopy.
Laparotomy with biopsy.
Treatment for dysmenorrhoea
إجراءات عامة2
Patients may be concerned about the possibility of underlying pathology and, when appropriate, reassurance and an explanation of the mechanism of menstrual pain may be helpful.
تغييرات في نمط الحياة - longitudinal studies have looked at risk factors for dysmenorrhoea and have found a clear association between smoking and dysmenorrhoea, with former smokers having a lower odds ratio for dysmenorrhoea than current smokers; patients should therefore be informed of this relationship and assisted in any attempts to stop smoking.8
There is low-quality evidence that exercise, performed for about 45 to 60 minutes each time, three times per week or more, regardless of intensity, may provide a clinically significant reduction in menstrual pain intensity. This includes activities such as relaxation exercises (progressive muscle relaxation and self-administered massage) and yoga, as well as aerobic exercise and strength training.910
Self-help techniques:
Spinal manipulation - there is no evidence for this, and a possibility of harm.1415
دوائي
NSAIDs appear to be a very effective treatment for dysmenorrhoea. However there is a significant risk of adverse effects.1
Ibuprofen is most often used due to its low incidence of side-effects. Although licensed specifically for dysmenorrhoea, there are concerns that mefenamic acid is more likely to induce seizures in overdose and has a low therapeutic window, increasing the risk of accidental overdose.2
Weak opioids - there is no evidence of beneficial effect and the potential for addiction means they are not recommended.
Hormonal treatments for dysmenorrhoea
If the woman with dysmenorrhoea does not wish to conceive, offer her hormonal contraception. Ovarian suppression appears to control cyclical pelvic pain, whether or not caused by endometriosis. Adolescents and young adults who do not respond to hormonal treatment after 3-6 should be evaluated for secondary causes of dysmenorrhoea. This is likely in approximately 10% of patients.
Combined hormonal contraception (CHC) is often used; tailored pill taking, including regimes such as three packets back to back followed by a four day break, or continuous pill taking, may improve dysmenorrhoea more than the traditional 21 day on, 7 days off regimens. Tailored pill taking is unlicensed but recommended in FSRH guidelines. 161718
Oral progestogen-only contraception may also be used, with evidence for both desogestrel and drospirenone pills.19
Depo-medroxyprogesterone acetate (Depo-Provera®) is also sometimes used, as many women become amenorrhoeic within a year of starting treatment; even for those who don't, dysmenorrhoea often improves.20
The levonorgestrel-containing intrauterine device (LNG-IUD) has been shown to reduce the severity of dysmenorrhoea despite not being anovulatory; none of the brands currently available in the UK have a license for this. It could also be considered, even in adolescents.21
الجراحة
Hysterectomy. In severe refractory cases, particularly in women who have completed their families, hysterectomy may be considered.
تحديثات حصرية لمتخصصي الرعاية الصحية
ابقَ على اطلاع بأحدث التحديثات السريرية، والرؤى المهنية، والإرشادات المستندة إلى الأدلة. تقوم نشرة Patient Pro الإخبارية بتجميع محتوى أساسي لمتخصصي الرعاية الصحية - يتم تسليمه مباشرة إلى بريدك الوارد.
من خلال الاشتراك، فإنك تقبل سياسة الخصوصية. يمكنك إلغاء الاشتراك في أي وقت. نحن لا نبيع بياناتك أبدًا.
قراءة إضافية ومراجع
- Nagy H, Carlson K, Khan MAB; Dysmenorrhea.
- Marjoribanks J, Ayeleke RO, Farquhar C, et al; Nonsteroidal anti-inflammatory drugs for dysmenorrhoea. Cochrane Database Syst Rev. 2015 Jul 30;(7):CD001751. doi: 10.1002/14651858.CD001751.pub3.
- عسر الطمث; NICE CKS، أكتوبر 2023 (الوصول متاح فقط في المملكة المتحدة)
- Ju H, Jones M, Mishra GD; A U-Shaped Relationship between Body Mass Index and Dysmenorrhea: A Longitudinal Study. PLoS One. 2015 Jul 28;10(7):e0134187. doi: 10.1371/journal.pone.0134187. eCollection 2015.
- Wu L, Zhang J, Tang J, et al; The relation between body mass index and primary dysmenorrhea: A systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2022 Dec;101(12):1364-1373. doi: 10.1111/aogs.14449. Epub 2022 Sep 20.
- Lindh I, Ellstrom AA, Milsom I; The effect of combined oral contraceptives and age on dysmenorrhoea: an epidemiological study. Hum Reprod. 2012 Mar;27(3):676-82. doi: 10.1093/humrep/der417. Epub 2012 Jan 17.
- Iacovides S, Avidon I, Baker FC; What we know about primary dysmenorrhea today: a critical review. Hum Reprod Update. 2015 Nov-Dec;21(6):762-78. doi: 10.1093/humupd/dmv039. Epub 2015 Sep 7.
- Juang CM, Yen MS, Twu NF, et al; Impact of pregnancy on primary dysmenorrhea. Int J Gynaecol Obstet. 2006 Mar;92(3):221-7. doi: 10.1016/j.ijgo.2005.12.006. Epub 2006 Jan 20.
- Qin LL, Hu Z, Kaminga AC, et al; Association between cigarette smoking and the risk of dysmenorrhea: A meta-analysis of observational studies. PLoS One. 2020 Apr 15;15(4):e0231201. doi: 10.1371/journal.pone.0231201. eCollection 2020.
- Armour M, Ee CC, Naidoo D, et al; Exercise for dysmenorrhoea. Cochrane Database Syst Rev. 2019 Sep 20;9:CD004142. doi: 10.1002/14651858.CD004142.pub4.
- Tsai IC, Hsu CW, Chang CH, et al; Comparative Effectiveness of Different Exercises for Reducing Pain Intensity in Primary Dysmenorrhea: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials. Sports Med Open. 2024 May 30;10(1):63. doi: 10.1186/s40798-024-00718-4.
- Niazi A, Moradi M; The Effect of Chamomile on Pain and Menstrual Bleeding in Primary Dysmenorrhea: A Systematic Review. Int J Community Based Nurs Midwifery. 2021 Jul;9(3):174-186. doi: 10.30476/ijcbnm.2021.87219.1417.
- Negi R, Sharma SK, Gaur R, et al; Efficacy of Ginger in the Treatment of Primary Dysmenorrhea: A Systematic Review and Meta-analysis. Cureus. 2021 Mar 6;13(3):e13743. doi: 10.7759/cureus.13743.
- Masoumi SZ, Asl HR, Poorolajal J, et al; Evaluation of mint efficacy regarding dysmenorrhea in comparison with mefenamic acid: A double blinded randomized crossover study. Iran J Nurs Midwifery Res. 2016 Jul-Aug;21(4):363-7. doi: 10.4103/1735-9066.185574.
- Cote P, Hartvigsen J, Axen I, et al; The global summit on the efficacy and effectiveness of spinal manipulative therapy for the prevention and treatment of non-musculoskeletal disorders: a systematic review of the literature. Chiropr Man Therap. 2021 Feb 17;29(1):8. doi: 10.1186/s12998-021-00362-9.
- Proctor ML, Hing W, Johnson TC, et al; Spinal manipulation for primary and secondary dysmenorrhoea. Cochrane Database Syst Rev. 2006 Jul 19;2006(3):CD002119. doi: 10.1002/14651858.CD002119.pub3.
- إرشادات FSRH السريرية: وسائل منع الحمل الهرمونية المركبة; كلية الرعاية الصحية الجنسية والإنجابية (يناير 2019 - تم التعديل في أكتوبر 2023)
- Schroll JB, Black AY, Farquhar C, et al; Combined oral contraceptive pill for primary dysmenorrhoea. Cochrane Database Syst Rev. 2023 Jul 31;7(7):CD002120. doi: 10.1002/14651858.CD002120.pub4.
- خيارات وسائل منع الحمل للشباب; كلية الرعاية الصحية الجنسية والإنجابية (2010 - تم التحديث في مايو 2019)
- حبوب البروجستوجين فقط؛ FSRH أغسطس 2022
- إرشادات سريرية لمنع الحمل بالحقن المحتوي على البروجستيرون فقط; كلية الرعاية الصحية الجنسية والإنجابية (ديسمبر 2014، معدلة 2023)
- The initial management of chronic pelvic pain; Royal College of Obstetricians and Gynaecologists (May 2012)
حول المراجععرض السيرة الذاتية الكاملة

الدكتورة فيليبا فينسنت، MRCGP
طبيب عام، مؤلف طبي
MB BS, Bsc, MRCGP (2000), DCH, DFSRH, DRCOG
الدكتورة فيليبا فينسنت هو طبيب عام في هيئة الخدمات الصحية الوطنية يعمل في شمال لندن.
تاريخ المقال
المقال متاح أيضًا باللغة الإنجليزية, الألمانية, إسبانية, الفرنسية, إيطالي, البرتغالية, الهندية, العبرية, العربية ,، و السويدية.
المراجعة التالية مستحقة: 6 مارس 2028
7 Mar 2025 | أحدث إصدار
المزيد في طب النساء
- انقطاع الطمث
- العدوى قبل الولادة وعواقبها
- كيس بارثولين والخراج
- أورام المبيض الحميدة
- وضعية الجنين المقعدية
- داء المبيضات
- سرطان عنق الرحم
- عدوى الكلاميديا التناسلية
- فرط تنسج بطانة الرحم
- الانتباذ البطاني الرحمي
- تشويه الأعضاء التناسلية الأنثوية
- الأورام الليفية
- التاريخ والفحص البولي التناسلي - أنثى
- علاجات العقم
- متلازمة تكيس المبايض
- نزيف ما بعد انقطاع الطمث
- قصور المبيض المبكر
- إنهاء الحمل
- علامات الورم
- التهاب الفرج


